GT Biopharma (GTBP) had the highest return between June 1, 2011 and May 31, 2013 by a US stock, returning 170,999,990%.
| ASSET | DATE | % RETURN |
|---|---|---|
GT Biopharma (GTBP) | 6/1/2011 - 5/31/2013 | 170,999,990% |
Color Star Technology (ADD) | 6/1/2011 - 5/31/2013 | 44,643,470.74% |
QXO (QXO) | 6/1/2011 - 5/31/2013 | 4,032,075% |
Castellum (CTM) | 6/1/2011 - 5/31/2013 | 325,986.92% |
Kartoon Studios (TOON) | 6/1/2011 - 5/31/2013 | 105,782.35% |
Nixxy (NIXX) | 6/1/2011 - 5/31/2013 | 23,300% |
BioLineRx (BLRX) | 6/1/2011 - 5/31/2013 | 15,793.78% |
Intellinetics (INLX) | 6/1/2011 - 5/31/2013 | 3,633.33% |
Nova Lifestyle I (NVFY) | 6/1/2011 - 5/31/2013 | 3,046.67% |
Actinium Pharmaceuticals (ATNM) | 6/1/2011 - 5/31/2013 | 2,718.18% |
Par Pacific (PARR) | 6/1/2011 - 5/31/2013 | 2,483.33% |
VerifyMe (VRME) | 6/1/2011 - 5/31/2013 | 2,001% |
Xpel (XPEL) | 6/1/2011 - 5/31/2013 | 1,233.33% |
Kazia Therapeutics Ltd ADR (KZIA) | 6/1/2011 - 5/31/2013 | 904.87% |
Nutex Health (NUTX) | 6/1/2011 - 5/31/2013 | 900% |
Rezolute (RZLT) | 6/1/2011 - 5/31/2013 | 880.77% |
Patrick Industries (PATK) | 6/1/2011 - 5/31/2013 | 766.27% |
Travere Therapeutics (TVTX) | 6/1/2011 - 5/31/2013 | 655.56% |
ACADIA Pharmaceuticals (ACAD) | 6/1/2011 - 5/31/2013 | 640.53% |
ZEN Graphene Solutions (ZTEK) | 6/1/2011 - 5/31/2013 | 636.84% |
MiMedx (MDXG) | 6/1/2011 - 5/31/2013 | 627.27% |
Consumer Portfolio Services (CPSS) | 6/1/2011 - 5/31/2013 | 606.36% |
Algorhythm (RIME) | 6/1/2011 - 5/31/2013 | 560.61% |
Coda Octopus (CODA) | 6/1/2011 - 5/31/2013 | 530% |
Cardiff Oncology (CRDF) | 6/1/2011 - 5/31/2013 | 450% |
